Want to find your lens? Five questions, no jargon — they tell you which of four reads fits how you already think.
We can't give an honest read on this one right now.
Our model values a company on the cash it can hand its owners after paying for its own growth. For Cencora that number is not something we can compute today — so rather than estimate around the gap, we are leaving it blank until the next filings close it.
Why not
- Caution: What is missingCencora has put its MWI Animal Health business up for sale — a $3.5B transaction — and moved its consulting and several international operations into an "Other" segment it is reviewing for divestiture. Its 2025 annual report still consolidates all of it. Our fair value compounds from five years of free cash flow, and the base would describe a company Cencora is actively taking apart. The read returns once the divestitures close and a full year has been filed without them.
Why show the page at all. Because the alternative is a number we don't believe. Every other company on TickerMath gets a fair value computed from its SEC filings; this one gets a plain explanation instead, which is the same promise kept a different way. This one is expected to change: we re-test every company against its new filings, and the read appears here as soon as the figures support it.
TickerMath is an educational tool, not investment advice — it computes one model from SEC filings and can be wrong. How we compute this →